Reagent EDTA

Hazard statements (CLP)

H312, H330

Code

Statements

H312

Harmful in contact with skin

SECTION 2: Hazards identification

According to Regulation (EC) No. 1272/2008 (CLP) Classification of the substance or mixture

Adverse physicochemical, human health and environmental effects

No additional information available

Hazard pictograms

GHS06

Signal word

Danger

Contains

SODIUM BORATE; Boric acid EPR

Hazard statements

H312 - Harmful in contact with skin. H330 - Fatal if inhaled.

Precautionary statements

P260 - Do not breathe dust/fume/gas/mist/vapours/spray. P304+P340 - IF INHALED: Remove victim to fresh air and keep at rest in a position comfortable for breathing. P310 - Immediately call a POISON CENTER or doctor/physician. P321 - Specific treatment (see supplemental first aid instruction on this label). P403+P233 - Store in a well-ventilated place. Keep container tightly closed.

2.3 Other hazards

This substance/mixture does not meet the PBT criteria of REACH regulation, annex XIII Contains no PBT/vPvB substances ≥ 0.1% assessed in accordance with REACH Annex XIII Component SODIUM BORATE (1330-43-4) This substance/mixture does not meet the PBT criteria of REACH regulation, annex XIII This substance/mixture does not meet the vPvB criteria of REACH regulation, annex XIII Boric acid EPR (10043-35-3) This substance/mixture does not meet the PBT criteria of REACH regulation, annex XIII This substance/mixture does not meet the vPvB criteria of REACH regulation, annex XIII The mixture does not contain substance(s) included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or is not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 Component SODIUM BORATE(1330-43-4) The substance is not included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or is not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 Boric acid EPR(10043-35-3) The substance is not included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or is not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605

2.1 Classification of the substance or mixture

Classification according to Regulation (EC) No. 1272/2008 [CLP] Acute toxicity (dermal), Category 4 H312 Acute toxicity (inhal.), Category 1 H330 Full text of H and EUH statements: see section 16 Adverse physicochemical, human health and environmental effects No additional information available